High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea.
Corneal collagen cross-linking (CXL) halts human corneal ectasias progression by increasing stromal mechanical stiffness. Although some reports describe that this procedure is effective in dealing with some infectious and immunologic corneal thinning diseases, there is a need for more animal models...
Main Authors: | Yirui Zhu, Peter S Reinach, Hanlei Zhu, Qiufan Tan, Qinxiang Zheng, Jia Qu, Wei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179580&type=printable |
Similar Items
-
Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases
by: E. V. Yani, et al.
Published: (2021-09-01) -
Changes in cornea structure after corneal collagen crosslinking in keratoconus
by: S. E. Avetisov, et al.
Published: (2022-04-01) -
Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review
by: M. M. Bikbov, et al.
Published: (2016-01-01) -
Effect of Riboflavin/UVA Collagen Cross-linking on Central Cornea, Limbus and Intraocular Pressure. Experimental Study in Rabbit Eyes
by: Vassilios Kozobolis, et al.
Published: (2016-10-01) -
Ultraviolet crosslinking of corneal collagen in patients with thin cornea. Literature review
by: A. V. Tereshchenko, et al.
Published: (2021-12-01)